Atherosclerotic Cardiovascular Disease Market Set to Exhibit Growth by 2032, Driven by Advancements and Emerging Therapies Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ...

Stroke Risk High When Anti-Clotting Drugs Stopped Study Highlights: Patients with irregular heartbeats who take anti-clotting medications are at high risk of stroke or blood clot whenever the drugs are stopped. The risks are similar...

AHA Perspective on FDA Committee Decision on Rivaroxaban DALLAS, Sept. 8, 2011 (GLOBE NEWSWIRE) -- The American Heart Association notes the FDA advisory committee's recommendation today to give market approval for rivaroxaban, an oral anticoagulant drug,...